0000899243-19-018656.txt : 20190701 0000899243-19-018656.hdr.sgml : 20190701 20190701174747 ACCESSION NUMBER: 0000899243-19-018656 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190627 FILED AS OF DATE: 20190701 DATE AS OF CHANGE: 20190701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CRAVES FRED B CENTRAL INDEX KEY: 0001014095 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 19934467 MAIL ADDRESS: STREET 1: 750 BATTERY ST STREET 2: STE 600 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MADRIGAL PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BARR HARBOR DRIVE, SUITE 400 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 404-380-9263 MAIL ADDRESS: STREET 1: 200 BARR HARBOR DRIVE, SUITE 400 CITY: WEST CONSHOHOCKEN STATE: PA ZIP: 19428 FORMER COMPANY: FORMER CONFORMED NAME: SYNTA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20010815 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-27 0 0001157601 MADRIGAL PHARMACEUTICALS, INC. MDGL 0001014095 CRAVES FRED B C/O BAY CITY CAPITAL, LLC 750 BATTERY STREET, SUITE 400 SAN FRANCISCO CA 94111 1 0 1 0 Stock Option (Right to Buy) 100.45 2019-06-27 4 A 0 10000 0.00 A 2024-06-27 Common Stock 10000 10000 D The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. /s/ Brian Lynch, as attorney-in-fact for Fred B. Craves 2019-07-01